Abstract:Abstract A well-established preclinical model of pancreatic cancer needs to be established to facilitate research on new therapeutic targets. Recently established animal models of pancreatic cancer, including patient-derived tumor models and organoid models, are used for pre-clinical drug testing and biomarker discovery. These models have useful characteristics over conventional xenograft mouse models based on cell lines in preclinical studies, but still cannot accurately predict the clinical outcomes of new treatments and have not yet been broadly implemented in research. We employed pancreatic cancer organoid culture methods using the pancreatic cancer cell line S2-013, and performed pathological and immunohistochemical analyses to characterize tumor xenografts obtained from a mouse model implanted with S2-013 cell line-derived organoids. Serum levels of the pancreatic cancer tumor marker CA19-9 were measured by ELISA. We generated human pancreatic cancer organoids using a co-culture of S2-013 cells, human endothelial cells derived from human umbilical vein endothelial cells, and human mesenchymal stem cells, and established a mouse model with subcutaneously transplanted human pancreatic cancer organoids (S2-013-organoid model). Although blood clotting crater-like formation developed in the middle of subcutaneous xenografts in the S2-013-conventional model, created by subcutaneously injecting S2-013 cells into the right flank of nude mice, the size of xenografts in the S2-013-organoid model gradually increased without crater-like formation. Importantly, tumor xenografts obtained from the S2-013-organoid model exhibited a clinical human pancreatic cancer tissue-like cellular morphology, tissue architecture, and polarity, and actively formed cancer stroma containing mature blood vessels with the high expression of the vascular tight junction marker CD31. In subcutaneous xenografts of S2-013-conventional mice, no blood vessel density or widely expanding areas of necrotic regions were present. Consequently, serum levels of CA19-9 in the S2-013-organoid model correlated with tumor volumes. In addition, epithelial–mesenchymal transition, the conversion of epithelial cells to the mesenchymal phenotype, was observed in tumor xenografts of the S2-013-organoid model. The S2-013-organoid model provides tumor xenografts consisting of clinical human pancreatic cancer-like tissue formation with the effective development of vascularized stroma, and may be valuable for facilitating studies on pre-clinical drug testing and biomarker discovery.

A novel simple suture method for establishing an orthotopic pancreatic cancer mouse model: a comparative study with two conventional methods

A Novel and Knotless Technique for Heterotopic Cardiac Transplantation in Mice

Establishment of Orthotopic Transplantation Nude Mouse Model with Pancreatic Cancer Celllines CFPAC

Establishment of an Orthotopic Pancreatic Cancer Mouse Model: Cells Suspended and Injected in Matrigel.

Comparative Study of Three Methods of Establishing Pancreatic Carcinoma Model in Nude Mice

Inoculation of Pan02 cells produces tumor nodules in mouse pancreas: Characterization of a novel orthotopic pancreatic ductal adenocarcinoma tumor model for interventional studies

Establishment of a mouse model of pancreatic cancer using human pancreatic cancer cell line S2-013-derived organoid

Subcutaneously Transplanted Human Pancreatic Cancer Tissue Fragments in a Mouse Model

Multi-Modality Imaging-Monitored Creation of Rat Orthotopic Pancreatic Head Cancer with Obstructive Jaundice

Mouse-Derived Allografts: A Complementary Model to the KPC Mice on Researching Pancreatic Cancer In Vivo

Establishment of Three Human Pancreatic Cancer Orthotopic Xenograft Nude Mice Models and Serum Metabolomics

Evaluation of encapsulated pancreatic tumor cells animal model

[Establishment and Evaluation of a Novel Mouse Model of Orthotopic Colon Cancer in the Mesenteric Triangle of the Cecum].

Comparison Of Two Syngeneic Orthotopic Murine Models Of Pancreatic Adenocarcinoma

Research progress in the establishment of pancreatic cancer models and preclinical applications

Identifying the Morphological and Molecular Features of a Cell-Based Orthotopic Pancreatic Cancer Mouse Model during Growth over Time

3.0T Magnetic Resonance Imaging of Pancreatic Cancer in an Orthotopic Nude Murine Model

Microencapsulated tumor assay: Evaluation of the nude mouse model of pancreatic cancer

Experimental animal models of pancreatic carcinogenesis and liver metastasis and me-tastasis-related molecules

Comparison of Orthotopically Implanted Mouse Models of Primary Breast Cancer Established by Different Methods

Clinical, Molecular and Genetic Validation of a Murine Orthotopic Xenograft Model of Pancreatic Adenocarcinoma Using Fresh Human Specimens